US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ceribell

12.91

+0.33002.62%

Post-market: 12.70-0.2092-1.62%19:32 EDT

Volume:636.79K

Turnover:8.22M

Market Cap:473.33M

PE:-7.12

High:13.29

Open:12.69

Low:12.68

Close:12.58

52wk High:32.75

52wk Low:10.01

Shares:36.66M

Float Shares:22.09M

Volume Ratio:1.17

T/O Rate:2.88%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8139

EPS(LYR):-3.3854

ROE:-51.39%

ROA:-24.91%

PB:2.75

PE(LYR):-3.81

Loading ...

Overview Company News Filings

CeriBell (CBLL) Q2 Revenue Jumps 38%

Stock Track | Ceribell Shares Plummet 7.06% as JP Morgan Slashes Price Target

U.S. RESEARCH ROUNDUP-Allstate, BP, Oracle

Ceribell, Inc. Reports Strong Q2 2025 Revenue Growth

Stock Track | Ceribell Soars 5.04% After-Hours on Strong Q2 Earnings and Raised Guidance

Stock Track | Ceribell Soars 5.04% After-Hours on Strong Q2 Earnings and Raised Guidance

CeriBell Q2 EPS $(0.38) Beats $(0.40) Estimate, Sales $21.199M Beat $20.528M Estimate

Ceribell Inc - Raises 2025 Revenue Guidance to $85-$88 Mln

THOMSON REUTERS

Ceribell Inc - Q2 2025 Revenue $21.2 Mln

THOMSON REUTERS

Ceribell Inc - Q2 2025 EPS $-0.38

THOMSON REUTERS

Ceribell Reports Second Quarter 2025 Financial Results

Ceribell, Inc.: Positioned for Growth with Strong Revenue Projections and Market Expansion Opportunities

CeriBell Inc expected to post a loss of 39 cents a share - Earnings Preview

Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025

Ceribell, Inc.’s Strategic Positioning and Patent Strength Justify Buy Rating

Ceribell Inc. CEO Xingjuan Chao Reports Disposal of Common Shares

BRIEF-Ceribell Files Complaints Against Natus For Patent Infringement

Ceribell files complaints against Natus Medical, alleges patent infringement

Ceribell Inc. Files Patent Infringement Complaints Against Natus Medical Over EEG Technology

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBLL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBLL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","market":"US","secType":"STK","nameCN":"Ceribell","latestPrice":12.91,"timestamp":1754683200000,"preClose":12.58,"halted":0,"volume":636792,"hourTrading":{"tag":"盘后","latestPrice":12.7008,"preClose":12.91,"latestTime":"19:32 EDT","volume":10577,"amount":136516.0276,"timestamp":1754695928492},"delay":0,"floatShares":22085538,"shares":36663968,"eps":-1.813927,"marketStatus":"Market Closed","change":0.33,"latestTime":"08-08 16:00:00 EDT","open":12.69,"high":13.285,"low":12.68,"amount":8216690.194752,"amplitude":0.048092,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.813927,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754899200000},"marketStatusCode":7,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":12.58,"preHourTrading":{"tag":"盘前","latestPrice":12.83,"preClose":12.58,"latestTime":"09:23 EDT","volume":160,"amount":2052.8,"timestamp":1754659434635},"postHourTrading":{"tag":"盘后","latestPrice":12.7008,"preClose":12.91,"latestTime":"19:32 EDT","volume":10577,"amount":136516.0276,"timestamp":1754695928492},"volumeRatio":1.1719966628563678,"impliedVol":0.5779,"impliedVolPercentile":0.3158},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","floatShares":22085538,"roa":"-24.91%","roe":"-51.39%","lyrEps":-3.385363,"volumeRatio":1.1719966628563678,"shares":36663968,"dividePrice":0,"high":13.285,"amplitude":0.048092,"preClose":12.58,"low":12.68,"week52Low":10.01,"pbRate":"2.75","psRate":"6.11","week52High":32.7489,"institutionHeld":0,"latestPrice":12.91,"eps":-1.813927,"divideRate":0,"volume":636792,"delay":0,"ttmEps":-1.813927,"open":12.69,"prevYearClose":25.88,"prevWeekClose":14.14,"prevMonthClose":14.4,"prevQuarterClose":18.73,"fiveDayClose":14.14,"twentyDayClose":16.13,"sixtyDayClose":16.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-05","symbol":"CBLL","fiscalQuarterEnding":"2025/06","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2025-02-25","symbol":"CBLL","fiscalQuarterEnding":"2024/12","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-12","symbol":"CBLL","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1750824000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLL","date":"2025-08-08","current":-9.334238,"percent":1,"low":-31.439367,"twenty":-26.486932,"median":-18.789911,"eighty":-13.847375,"high":-9.334238,"avg":-19.705705,"sd":6.047645,"marketCap":461232717},"quantilePoints":[{"date":"2024-10-11","current":-17.636997,"twenty":-17.222009,"median":-16.599526,"eighty":-15.977044,"marketCap":578317118},{"date":"2024-10-18","current":-27.492965,"twenty":-27.233597,"median":-26.455495,"eighty":-19.29695,"marketCap":901494331},{"date":"2024-10-25","current":-28.702676,"twenty":-28.6853,"median":-27.456654,"eighty":-26.040507,"marketCap":941160750},{"date":"2024-10-31","current":-28.246561,"twenty":-28.615797,"median":-28.219411,"eighty":-26.455495,"marketCap":926204733},{"date":"2024-11-08","current":-31.439367,"twenty":-28.963313,"median":-28.463759,"eighty":-26.486619,"marketCap":1030896848},{"date":"2024-11-15","current":-27.13588,"twenty":-29.27825,"median":-28.458329,"eighty":-27.13588,"marketCap":981043460},{"date":"2024-11-22","current":-25.000572,"twenty":-28.963313,"median":-28.246561,"eighty":-25.93676,"marketCap":903845676},{"date":"2024-11-29","current":-28.528199,"twenty":-28.754803,"median":-28.246561,"eighty":-26.043953,"marketCap":1031379984},{"date":"2024-12-06","current":-28.022837,"twenty":-28.754803,"median":-28.33145,"eighty":-26.11912,"marketCap":1013109620},{"date":"2024-12-13","current":-28.934471,"twenty":-29.290749,"median":-28.463759,"eighty":-26.390638,"marketCap":1046067924},{"date":"2024-12-20","current":-26.486932,"twenty":-29.217263,"median":-28.434619,"eighty":-26.480394,"marketCap":957582042},{"date":"2024-12-27","current":-26.239205,"twenty":-29.058794,"median":-28.293244,"eighty":-26.474169,"marketCap":948625981},{"date":"2025-01-03","current":-25.624843,"twenty":-28.959703,"median":-28.107549,"eighty":-26.162518,"marketCap":926414949},{"date":"2025-01-10","current":-22.810668,"twenty":-28.950325,"median":-27.629083,"eighty":-25.703081,"marketCap":824674096},{"date":"2025-01-17","current":-19.966767,"twenty":-28.888112,"median":-27.428293,"eighty":-25.067954,"marketCap":721858516},{"date":"2025-01-24","current":-22.860214,"twenty":-28.702676,"median":-27.180566,"eighty":-24.06912,"marketCap":826465309},{"date":"2025-01-31","current":-23.583576,"twenty":-28.691816,"median":-26.734658,"eighty":-23.038577,"marketCap":852617007},{"date":"2025-02-07","current":-22.404397,"twenty":-28.676835,"median":-26.675204,"eighty":-22.810668,"marketCap":809986156},{"date":"2025-02-14","current":-21.700853,"twenty":-28.676835,"median":-26.471057,"eighty":-22.741305,"marketCap":784550943},{"date":"2025-02-21","current":-22.89985,"twenty":-28.628005,"median":-26.224342,"eighty":-22.412324,"marketCap":827898278},{"date":"2025-02-28","current":-21.066166,"twenty":-28.554982,"median":-26.070751,"eighty":-22.392506,"marketCap":852231734},{"date":"2025-03-07","current":-19.700766,"twenty":-28.530515,"median":-25.634752,"eighty":-21.924596,"marketCap":796994492},{"date":"2025-03-14","current":-18.973735,"twenty":-28.528199,"median":-25.33748,"eighty":-21.562126,"marketCap":767582454},{"date":"2025-03-21","current":-17.971851,"twenty":-28.50271,"median":-25.099663,"eighty":-21.066166,"marketCap":727051231},{"date":"2025-03-28","current":-17.581737,"twenty":-28.470275,"median":-24.772663,"eighty":-20.685126,"marketCap":711269162},{"date":"2025-04-04","current":-16.606451,"twenty":-28.455071,"median":-23.826348,"eighty":-20.087337,"marketCap":671813989},{"date":"2025-04-11","current":-9.885848,"twenty":-28.423651,"median":-23.117849,"eighty":-19.576639,"marketCap":399931979},{"date":"2025-04-17","current":-12.847169,"twenty":-28.370492,"median":-23.028668,"eighty":-18.81521,"marketCap":519732232},{"date":"2025-04-25","current":-13.733792,"twenty":-28.283907,"median":-22.880032,"eighty":-18.236951,"marketCap":555600571},{"date":"2025-05-02","current":-14.434225,"twenty":-28.213982,"median":-22.800759,"eighty":-17.779392,"marketCap":583936558},{"date":"2025-05-09","current":-13.718069,"twenty":-28.090607,"median":-22.74626,"eighty":-17.175663,"marketCap":613348596},{"date":"2025-05-16","current":-14.219225,"twenty":-27.868255,"median":-22.414306,"eighty":-16.62773,"marketCap":635755756},{"date":"2025-05-23","current":-13.952463,"twenty":-27.601859,"median":-22.343922,"eighty":-15.355632,"marketCap":623828559},{"date":"2025-05-30","current":-13.758454,"twenty":-27.480147,"median":-22.032807,"eighty":-14.513655,"marketCap":615154234},{"date":"2025-06-06","current":-14.146471,"twenty":-27.447869,"median":-21.770217,"eighty":-14.377951,"marketCap":632502885},{"date":"2025-06-13","current":-14.696163,"twenty":-27.425113,"median":-21.443217,"eighty":-14.356933,"marketCap":657080139},{"date":"2025-06-20","current":-14.388982,"twenty":-27.372387,"median":-21.160809,"eighty":-14.341496,"marketCap":643345791},{"date":"2025-06-27","current":-15.593453,"twenty":-27.171629,"median":-21.066166,"eighty":-14.347335,"marketCap":697198894},{"date":"2025-07-03","current":-15.30244,"twenty":-27.13588,"median":-20.739674,"eighty":-14.354429,"marketCap":684187406},{"date":"2025-07-11","current":-13.548278,"twenty":-26.734658,"median":-20.627807,"eighty":-14.324313,"marketCap":605757048},{"date":"2025-07-18","current":-12.626736,"twenty":-26.734658,"median":-20.117479,"eighty":-14.18689,"marketCap":564554003},{"date":"2025-07-25","current":-12.432727,"twenty":-26.675204,"median":-19.774312,"eighty":-13.960546,"marketCap":555879678},{"date":"2025-08-01","current":-11.640525,"twenty":-26.675204,"median":-19.115595,"eighty":-13.895877,"marketCap":520459516},{"date":"2025-08-08","current":-9.334238,"twenty":-26.486932,"median":-18.789911,"eighty":-13.847375,"marketCap":461232717}],"updateTime":1754823560351},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBLL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557630482","title":"CeriBell (CBLL) Q2 Revenue Jumps 38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557630482","media":"Motley Fool","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557630482?lang=en_us&edition=fundamental","pubTime":"2025-08-07 02:52","pubTimestamp":1754506320,"startTime":"0","endTime":"0","summary":"Revenue  grew 38% to $21.2 million in Q2 2025, beating the analyst estimate by $0.75 million .Gross margin reached 88%, rising from 86% in Q2 2024.Operating expenses climbed 56%, widening the net loss to $13.6 million .","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2e67fde4d458002cf59f26acf09dd58f97b62ce0-1024x1024.png&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2e67fde4d458002cf59f26acf09dd58f97b62ce0-1024x1024.png&op=resize&w=165&h=104"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/data-news/2025/08/06/ceribell-cbll-q2-revenue-jumps-38/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["CBLL"],"gpt_icon":0},{"id":"1188919327","title":"Stock Track | Ceribell Shares Plummet 7.06% as JP Morgan Slashes Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1188919327","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188919327?lang=en_us&edition=fundamental","pubTime":"2025-08-06 21:48","pubTimestamp":1754488097,"startTime":"0","endTime":"0","summary":"Ceribell (CBLL) stock plummeted 7.06% in pre-market trading on Wednesday after JP Morgan analysts cut their price target for the company. The significant downward revision has sparked concerns among...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CBLL"],"gpt_icon":0},{"id":"2557329340","title":"U.S. RESEARCH ROUNDUP-Allstate, BP, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2557329340","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557329340?lang=en_us&edition=fundamental","pubTime":"2025-08-06 16:05","pubTimestamp":1754467552,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Allstate, BP, OracleAug 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Allstate, BP, and Oracle","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nL4N3TY0MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APPF","ANET","CMA","FIS","IE00BMG7P819.SGD","INVH","LU1935042215.USD","ALNY","BLD","KMPR","LDOS","LU0057025933.USD","ORCL","IAC","ALL","BK4572","HHH","GFS","HOLX","MTCH","NEE","BWIN","XYZ","BL","CAKE","LU1037948897.HKD","FOXA","CAT","AL","LU2326559502.SGD","CBLL","HLNE","MASI","CL","IDYA","DD","ATKR","DRVN","EXPD","CMI","KD","ONIT","LU0823421416.USD","AEIS","ACHC","LU0069063385.USD","LU2054465674.USD"],"gpt_icon":1},{"id":"2557411347","title":"Ceribell, Inc. Reports Strong Q2 2025 Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2557411347","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557411347?lang=en_us&edition=fundamental","pubTime":"2025-08-06 13:14","pubTimestamp":1754457250,"startTime":"0","endTime":"0","summary":"Ceribell, Inc. ( ($CBLL) ) has released its Q2 earnings. Here is a breakdown of the information Ceribell, Inc. presented to its investors. Ceribell...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-reports-strong-q2-2025-revenue-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-reports-strong-q2-2025-revenue-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"1178806527","title":"Stock Track | Ceribell Soars 5.04% After-Hours on Strong Q2 Earnings and Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1178806527","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178806527?lang=en_us&edition=fundamental","pubTime":"2025-08-06 05:02","pubTimestamp":1754427743,"startTime":"0","endTime":"0","summary":"Ceribell (NASDAQ: CBLL) saw its stock price surge 5.04% in after-hours trading on Tuesday, following the release of its impressive second-quarter 2025 financial results and an upward revision of its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CBLL"],"gpt_icon":0},{"id":"1176862192","title":"Stock Track | Ceribell Soars 5.04% After-Hours on Strong Q2 Earnings and Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1176862192","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176862192?lang=en_us&edition=fundamental","pubTime":"2025-08-06 05:02","pubTimestamp":1754427741,"startTime":"0","endTime":"0","summary":"Ceribell (NASDAQ:CBLL) saw its stock price surge 5.04% in after-hours trading on Tuesday, following the release of its impressive second-quarter 2025 earnings report. The medical technology company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CBLL"],"gpt_icon":0},{"id":"2557311176","title":"CeriBell Q2 EPS $(0.38) Beats $(0.40) Estimate, Sales $21.199M Beat $20.528M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557311176","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557311176?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:15","pubTimestamp":1754424910,"startTime":"0","endTime":"0","summary":"CeriBell (NASDAQ:CBLL) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.40) by 4.52 percent.  The company reported quarterly sales of $21.199 million which beat the analyst","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46871858/ceribell-q2-eps-0-38-beats-0-40-estimate-sales-21-199m-beat-20-528m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CeriBell Q2 EPS $(0.38) Beats $(0.40) Estimate, Sales $21.199M Beat $20.528M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0},{"id":"2557314754","title":"Ceribell Inc - Raises 2025 Revenue Guidance to $85-$88 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2557314754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557314754?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:05","pubTimestamp":1754424305,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nTUA9W0RZP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2557244314","title":"Ceribell Inc - Q2 2025 Revenue $21.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2557244314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557244314?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:05","pubTimestamp":1754424305,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nTUA9W0RZP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2557147533","title":"Ceribell Inc - Q2 2025 EPS $-0.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2557147533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557147533?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:05","pubTimestamp":1754424305,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nTUA9W0RZP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2557317857","title":"Ceribell Reports Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557317857","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557317857?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:05","pubTimestamp":1754424300,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., Aug.  05, 2025  (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/05/3127815/0/en/Ceribell-Reports-Second-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2556874523","title":"Ceribell, Inc.: Positioned for Growth with Strong Revenue Projections and Market Expansion Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2556874523","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556874523?lang=en_us&edition=fundamental","pubTime":"2025-08-04 10:55","pubTimestamp":1754276112,"startTime":"0","endTime":"0","summary":"Analyst Josh Jennings of TD Cowen maintained a Buy rating on Ceribell, Inc., retaining the price target of $36.00. Josh Jennings has given his Buy ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-inc-positioned-for-growth-with-strong-revenue-projections-and-market-expansion-opportunities-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-inc-positioned-for-growth-with-strong-revenue-projections-and-market-expansion-opportunities-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2556849934","title":"CeriBell Inc  expected to post a loss of 39 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556849934","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556849934?lang=en_us&edition=fundamental","pubTime":"2025-08-02 06:25","pubTimestamp":1754087106,"startTime":"0","endTime":"0","summary":"CeriBell Inc  expected to post a loss of39cents a share - Earnings Preview CeriBell Inc CBLL.OQ CBLL.O is expected to  report resultson August 5 for the period ending June 30 2025The Sunnyvale Califor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nL8N3TT36B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0},{"id":"2555069109","title":"Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2555069109","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555069109?lang=en_us&edition=fundamental","pubTime":"2025-07-30 04:05","pubTimestamp":1753819500,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., July  29, 2025  (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/29/3123595/0/en/Ceribell-to-Participate-in-the-Canaccord-Genuity-45th-Annual-Growth-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2553630682","title":"Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553630682","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553630682?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:05","pubTimestamp":1753214700,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., July  22, 2025  (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with se","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/22/3119846/0/en/Ceribell-to-Report-Second-Quarter-2025-Financial-Results-on-August-5-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2550966634","title":"Ceribell, Inc.’s Strategic Positioning and Patent Strength Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550966634?lang=en_us&edition=fundamental","pubTime":"2025-07-10 05:35","pubTimestamp":1752096912,"startTime":"0","endTime":"0","summary":"William Blair analyst Brandon Vazquez has maintained their bullish stance on CBLL stock, giving a Buy rating on June 24. Brandon Vazquez has given ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-inc-s-strategic-positioning-and-patent-strength-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-inc-s-strategic-positioning-and-patent-strength-justify-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2550509676","title":"Ceribell Inc. CEO Xingjuan Chao Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2550509676","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550509676?lang=en_us&edition=fundamental","pubTime":"2025-07-10 02:49","pubTimestamp":1752086990,"startTime":"0","endTime":"0","summary":"Xingjuan  Chao, President and CEO of Ceribell Inc., reported a disposal of common shares of Ceribell Inc., as per the Form 4 filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDLbPkGNJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2549456399","title":"BRIEF-Ceribell Files Complaints Against Natus For Patent Infringement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549456399","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549456399?lang=en_us&edition=fundamental","pubTime":"2025-07-08 06:06","pubTimestamp":1751926016,"startTime":"0","endTime":"0","summary":"BRIEF-Ceribell Files Complaints Against Natus For Patent InfringementJuly 7 (Reuters) - CeriBell Inc CBLL.O:CERIBELL INC - FILES COMPLAINTS AGAINST NATUS FOR PATENT INFRINGEMENTCERIBELL INC - CLAIMS N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nFWN3T408A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2549688215","title":"Ceribell files complaints against Natus Medical, alleges patent infringement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549688215","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549688215?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:50","pubTimestamp":1751921449,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) announced that it filed complaints against Natus Medical Incorporated and related subsidiaries, alleging patent infringement and un...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-files-complaints-against-natus-medical-alleges-patent-infringement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-files-complaints-against-natus-medical-alleges-patent-infringement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","NTUS","BK4082"],"gpt_icon":0},{"id":"2549550247","title":"Ceribell Inc. Files Patent Infringement Complaints Against Natus Medical Over EEG Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2549550247","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549550247?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:42","pubTimestamp":1751920979,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ceribell Inc. published the original content used to generate this news brief via GlobeNewswire  on July 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDLJsJWg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","CBLL","BK4112","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","BK4585","IE00BKPKM429.USD","BK4082","LU2095319765.USD","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":70,"code":"91000000","status":"200"}]}}